147 related articles for article (PubMed ID: 37503730)
1. NF-
Jiang Y; Zhang J; Shi C; Li X; Jiang Y; Mao R
Expert Rev Mol Med; 2023 Jul; 25():e25. PubMed ID: 37503730
[TBL] [Abstract][Full Text] [Related]
2. A hypoxia-dependent upregulation of hypoxia-inducible factor-1 by nuclear factor-κB promotes gastric tumour growth and angiogenesis.
Nam SY; Ko YS; Jung J; Yoon J; Kim YH; Choi YJ; Park JW; Chang MS; Kim WH; Lee BL
Br J Cancer; 2011 Jan; 104(1):166-74. PubMed ID: 21119667
[TBL] [Abstract][Full Text] [Related]
3. NF-kappaB as a potential molecular target for cancer therapy.
Lee CH; Jeon YT; Kim SH; Song YS
Biofactors; 2007; 29(1):19-35. PubMed ID: 17611291
[TBL] [Abstract][Full Text] [Related]
4. NF-kappaB as a therapeutic target in cancer.
Orlowski RZ; Baldwin AS
Trends Mol Med; 2002 Aug; 8(8):385-9. PubMed ID: 12127724
[TBL] [Abstract][Full Text] [Related]
5. Pinitol targets nuclear factor-kappaB activation pathway leading to inhibition of gene products associated with proliferation, apoptosis, invasion, and angiogenesis.
Sethi G; Ahn KS; Sung B; Aggarwal BB
Mol Cancer Ther; 2008 Jun; 7(6):1604-14. PubMed ID: 18566231
[TBL] [Abstract][Full Text] [Related]
6. Cryptopleurine targets NF-κB pathway, leading to inhibition of gene products associated with cell survival, proliferation, invasion, and angiogenesis.
Jin HR; Jin SZ; Cai XF; Li D; Wu X; Nan JX; Lee JJ; Jin X
PLoS One; 2012; 7(6):e40355. PubMed ID: 22768286
[TBL] [Abstract][Full Text] [Related]
7. Epigenetically upregulated oncoprotein PLCE1 drives esophageal carcinoma angiogenesis and proliferation via activating the PI-PLCε-NF-κB signaling pathway and VEGF-C/ Bcl-2 expression.
Chen Y; Wang D; Peng H; Chen X; Han X; Yu J; Wang W; Liang L; Liu Z; Zheng Y; Hu J; Yang L; Li J; Zhou H; Cui X; Li F
Mol Cancer; 2019 Jan; 18(1):1. PubMed ID: 30609930
[TBL] [Abstract][Full Text] [Related]
8. Medicinal Plants in Cancer Treatment: Contribution of Nuclear Factor- Kappa B (NF-kB) Inhibitors.
Das R; Mehta DK; Dhanawat M
Mini Rev Med Chem; 2022; 22(15):1938-1962. PubMed ID: 35260052
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of NF-κB signaling pathway induces apoptosis and suppresses proliferation and angiogenesis of human fibroblast-like synovial cells in rheumatoid arthritis.
Xia ZB; Meng FR; Fang YX; Wu X; Zhang CW; Liu Y; Liu D; Li GQ; Feng FB; Qiu HY
Medicine (Baltimore); 2018 Jun; 97(23):e10920. PubMed ID: 29879032
[TBL] [Abstract][Full Text] [Related]
10. MiR-130b/TNF-α/NF-κB/VEGFA loop inhibits prostate cancer angiogenesis.
Mu HQ; He YH; Wang SB; Yang S; Wang YJ; Nan CJ; Bao YF; Xie QP; Chen YH
Clin Transl Oncol; 2020 Jan; 22(1):111-121. PubMed ID: 31667686
[TBL] [Abstract][Full Text] [Related]
11. Targeting non-canonical nuclear factor-κB signalling attenuates neovascularization in a novel 3D model of rheumatoid arthritis synovial angiogenesis.
Maracle CX; Kucharzewska P; Helder B; van der Horst C; Correa de Sampaio P; Noort AR; van Zoest K; Griffioen AW; Olsson H; Tas SW
Rheumatology (Oxford); 2017 Feb; 56(2):294-302. PubMed ID: 27864565
[TBL] [Abstract][Full Text] [Related]
12. The antitumor effect of a novel angiogenesis inhibitor (an octahydronaphthalene derivative) targeting both VEGF receptor and NF-κB pathway.
Watari K; Nakamura M; Fukunaga Y; Furuno A; Shibata T; Kawahara A; Hosoi F; Kuwano T; Kuwano M; Ono M
Int J Cancer; 2012 Jul; 131(2):310-21. PubMed ID: 21826646
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-2 induces NF-kappaB activation through BCL10 and affects its subcellular localization in natural killer lymphoma cells.
Chan KK; Shen L; Au WY; Yuen HF; Wong KY; Guo T; Wong ML; Shimizu N; Tsuchiyama J; Kwong YL; Liang RH; Srivastava G
J Pathol; 2010 Jun; 221(2):164-74. PubMed ID: 20235165
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of platelet-derived growth factor-D inhibits cell growth and angiogenesis through inactivation of Notch-1 and nuclear factor-kappaB signaling.
Wang Z; Kong D; Banerjee S; Li Y; Adsay NV; Abbruzzese J; Sarkar FH
Cancer Res; 2007 Dec; 67(23):11377-85. PubMed ID: 18056465
[TBL] [Abstract][Full Text] [Related]
15. Coronarin D, a labdane diterpene, inhibits both constitutive and inducible nuclear factor-kappa B pathway activation, leading to potentiation of apoptosis, inhibition of invasion, and suppression of osteoclastogenesis.
Kunnumakkara AB; Ichikawa H; Anand P; Mohankumar CJ; Hema PS; Nair MS; Aggarwal BB
Mol Cancer Ther; 2008 Oct; 7(10):3306-17. PubMed ID: 18852134
[TBL] [Abstract][Full Text] [Related]
16. NF-κB-inducing kinase is a key regulator of inflammation-induced and tumour-associated angiogenesis.
Noort AR; van Zoest KP; Weijers EM; Koolwijk P; Maracle CX; Novack DV; Siemerink MJ; Schlingemann RO; Tak PP; Tas SW
J Pathol; 2014 Nov; 234(3):375-85. PubMed ID: 25043127
[TBL] [Abstract][Full Text] [Related]
17. Bortezomib-enhanced radiosensitization through the suppression of radiation-induced nuclear factor-κB activity in human oral cancer cells.
Tamatani T; Takamaru N; Hara K; Kinouchi M; Kuribayashi N; Ohe G; Uchida D; Fujisawa K; Nagai H; Miyamoto Y
Int J Oncol; 2013 Mar; 42(3):935-44. PubMed ID: 23340716
[TBL] [Abstract][Full Text] [Related]
18. Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-kappaB-regulated gene products and TAK1-mediated NF-kappaB activation.
Sethi G; Ahn KS; Pandey MK; Aggarwal BB
Blood; 2007 Apr; 109(7):2727-35. PubMed ID: 17110449
[TBL] [Abstract][Full Text] [Related]
19. Research progress of the structure and function of NF-κB and IκB in different animal groups.
Su P; Feng SS; Li QW
Yi Chuan; 2016 Jun; 38(6):523-531. PubMed ID: 27655314
[TBL] [Abstract][Full Text] [Related]
20. Engineered nanoparticles as emerging gene/drug delivery systems targeting the nuclear factor-κB protein and related signaling pathways in cancer.
Eskandani R; Kazempour M; Farahzadi R; Sanaat Z; Eskandani M; Adibkia K; Vandghanooni S; Mokhtarzadeh A
Biomed Pharmacother; 2022 Dec; 156():113932. PubMed ID: 36411621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
